Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Gainers

• Ainos, Inc. AIMD shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.
• Intuitive Machines, Inc. LUNR shares gained 29.1% to $11.02 in pre-market trading. Intuitive Machines is closing in on delivering its Nova-C lunar lander to Florida for launch. The company said on Thursday that it has successfully conducted a complete spacecraft test run of the lander.
• Nikola Corporation NKLA shares rose 20.7% to $2.68 in pre-market trading after gaining over 60% on Thursday. The company and BayoTech announced an agreement to advance reliable hydrogen supply for zero-emission commercial fuel cell electric vehicle fleets.
• ARB IOT Group Limited ARBB shares rose 20.3% to $3.92 in pre-market trading after gaining around 12% on Thursday.
• ACADIA Pharmaceuticals Inc. ACAD gained 20.2% to $31.00 in pre-market trading. Acadia Pharmaceuticals acquired ex-North American rights to trofinetide and global rights to Neuren's NNZ-2591 in Rett syndrome and Fragile X syndrome.
• OKYO Pharma Limited OKYO shares climbed 18.8% to $1.28 in pre-market trading after adding around 4% on Thursday.
• 1847 Holdings LLC EFSH rose 16.8% to $0.2920 in pre-market trading. 1847 projects revenue of $20 million for the second quarter.
• Taoping Inc. TAOP rose 16.3% to $0.6499 in pre-market trading after declining around 7% on Thursday. Taoping recently reported 1H 2023 contract revenue of roughly $14.65 million, up 95% year over year.
• GT Biopharma, Inc. GTBP shares gained 13.9% to $0.3201 in pre-market trading.
• Aehr Test Systems AEHR gained 4.4% to $43.23 in pre-market trading as the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 revenue to be at least $100 million and GAAP net income of at least $28 million.

Losers

• Theseus Pharmaceuticals, Inc. THRX fell 67.6% to $3.08 in pre-market trading after the company announced plans to discontinue enrollment in Phase 1/2 study and terminate development of THE-630 in patients with GIST.
• Leslie's, Inc. LESL fell 27.8% to $6.87 in pre-market trading after the company released preliminary results for its fiscal third quarter and announced a CFO transition. The company said it expects fiscal third-quarter revenue to come in at $611 million versus estimates of $703.74 million and seed adjusted earnings in a range of 39 cents to 41 cents per share versus estimates of 69 cents per share. Leslie's also announced that CFO Steve Weddell is stepping down from his role, effective Aug. 7.
• EdtechX Holdings Acquisition Corp. II EDTX fell 14.1% to $37.16 in pre-market trading after jumping 203% on Thursday.
• Fresh Vine Wine, Inc. VINE fell 9.7% to $0.5299 in pre-market trading after gaining over 12% on Thursday.
• Nokia Oyj NOK shares fell 9.4% to $3.94 in pre-market trading after the company reduced net sales guidance and narrowed its operating margin outlook for 2023.
• Aridis Pharmaceuticals, Inc. ARDS fell 8.7% to $0.3205 in pre-market. Aridis recently announced FDA Qualified Infectious Disease Product Designation for AR-301.
• Telefonaktiebolaget LM Ericsson ERIC shares fell 8.2% to $5.27 in pre-market trading after the company posted a loss for the second quarter.
• Jiuzi Holdings, Inc. JZXN shares fell 8.1% to $3.73 in pre-market trading after climbing over 45% on Thursday.
• Ault Alliance, Inc. AULT fell 8.1% to $3.87 in pre-market trading after declining over 20% on Thursday. Ault Alliance recently announced a second partial distribution of TOG Securities of approximately $0.37 for each share of Ault Alliance common stock.
• Evogene Ltd. EVGN fell 7.1% to $1.31 in pre-market trading after gaining 12% on Thursday.

Now Read This: Top 5 Materials Stocks That Should Keep You Up At Night